Activation of Receptor Activator of NF-κB Ligand Gene Expression by 1,25-Dihydroxyvitamin D₃ Is Mediated through Multiple Long-Range Enhancers

REFERENCES

• Bettoun, D. J., T. P. Burris, K. A. Houck, D. W. Buck II, K. R. Stayrook, B. Khalifa, J. Lu, W. W. Chin, and S. Nagpal. 2003. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Mol. Endocrinol. 17:2320–2328. [Epub ahead of print.]
   PubMedGoogle Scholar
• Carroll, J. S., X. S. Liu, A. S. Brodsky, W. Li, C. A. Meyer, A. J. Szary, J. Eeckhoute, W. Shao, E. V. Hestermann, T. R. Geistlinger, E. A. Fox, P. A. Silver, and M. Brown. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33–43.
   PubMed Web of Science ®Google Scholar
• Cawley, S., S. Bekiranov, H. H. Ng, P. Kapranov, E. A. Sekinger, D. Kampa, A. Piccolboni, V. Sementchenko, J. Cheng, A. J. Williams, R. Wheeler, B. Wong, J. Drenkow, M. Yamanaka, S. Patel, S. Brubaker, H. Tammana, G. Helt, K. Struhl, and T. R. Gingeras. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116:499–509.
   PubMed Web of Science ®Google Scholar
• Cheng, J., P. Kapranov, J. Drenkow, S. Dike, S. Brubaker, S. Patel, J. Long, D. Stern, H. Tammana, G. Helt, V. Sementchenko, A. Piccolboni, S. Bekiranov, D. K. Bailey, M. Ganesh, S. Ghosh, I. Bell, D. S. Gerhard, and T. R. Gingeras. 2005. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 308:1149–1154. [Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• Cosgrove, M. S., J. D. Boeke, and C. Wolberger. 2004. Regulated nucleosome mobility and the histone code. Nat. Struct. Mol. Biol. 11:1037–1043.
   PubMed Web of Science ®Google Scholar
• de Bruin, D., Z. Zaman, R. A. Liberatore, and M. Ptashne. 2001. Telomere looping permits gene activation by a downstream UAS in yeast. Nature 409:109–113.
   PubMedGoogle Scholar
• Dekker, J., K. Rippe, M. Dekker, and N. Kleckner. 2002. Capturing chromosome conformation. Science 295:1306–1311.
   PubMed Web of Science ®Google Scholar
• Dhawan, P., X. Peng, A. L. M. Sutton, P. N. MacDonald, C. M. Croniger, C. Trautwein, M. Centrella, T. L. McCarthy, and S. Christakos. 2005. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase. Mol. Cell. Biol. 25:472–487.
   PubMed Web of Science ®Google Scholar
• Drissen, R., R. J. Palstra, N. Gillemans, E. Splinter, F. Grosveld, S. Philipsen, and W. de Laat. 2004. The active spatial organization of the beta-globin locus requires the transcription factor EKLF. Genes Dev. 18:2485–2490.
   PubMed Web of Science ®Google Scholar
• ENCODE Project Consortium. 2004. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306:636–640.
   PubMed Web of Science ®Google Scholar
• Fan, X., E. M. Roy, T. C. Murphy, M. S. Nanes, S. Kim, J. W. Pike, and J. Rubin. 2004. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells. J. Cell Biochem. 93:807–818.
   PubMedGoogle Scholar
• Fu, Q., R. L. Jilka, S. C. Manolagas, and C. A. O'Brien. 2002. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J. Biol. Chem. 277:48868–48875. [Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• Fu, Q., S. C. Manolagas, and C. A. O'Brien. Parathyroid hormone controls receptor activator of NF-κB ligand gene expression via a distant transcriptional enhancer. Mol. Cell. Biol. 26:6453–6468.
   PubMedGoogle Scholar
• Glynn, E. F., P. C. Megee, H. G. Yu, C. Mistrot, E. Unal, D. E. Koshland, J. L. Derisi, and J. L. Gerton. 2004. Genome-wide mapping of the cohesion complex in the yeast Saccharomyces cerevisiae. PLoS Biol. 2:E259. [Online.]
   PubMed Web of Science ®Google Scholar
• Gribnau, J., K. Diderich, S. Pruzina, R. Calzolari, and P. Fraser. 2000. Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus. Mol. Cell 5:377–386.
   PubMedGoogle Scholar
• Groyer, A., G. Schweizer-Groyer, F. Cadepond, M. Mariller, and E. E. Baulieu. 1987. Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro. Nature 328:624–626.
   PubMed Web of Science ®Google Scholar
• Harris, W. H., and R. P. Heaney. 1969. Skeletal renewal and metabolic bone disease. N. Engl. J. Med. 280:193–202.
   PubMed Web of Science ®Google Scholar
• Hofbauer, L. C., F. Gori, L. Riggs, D. L. Lacey, C. R. Dunstan, T. C. Spelsberg, and S. Khosla. 1999. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382–4389.
   PubMed Web of Science ®Google Scholar
• Hofbauer, L. C., S. Khosla, C. R. Dunstan, D. L. Lacey, W. J. Boyle, and B. L. Riggs. 2000. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J. Bone Miner. Res. 15:2–12.
   PubMed Web of Science ®Google Scholar
• Hsu, H., D. L. Lacey, C. R. Dunstan, I. Solovyev, A. Colombero, E. Timms, H. L. Tan, G. Elliott, M. J. Kelley, I. Sarosi, L. Wang, X. Z. Xia, R. Elliott, L. Chiu, T. Black, S. Scully, C. Capparelli, S. Morony, G. Shimamoto, M. B. Bass, and W. J. Boyle. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 96:3540–3545.
   PubMed Web of Science ®Google Scholar
• Impey, S., S. R. McCorkle, H. Cha-Molstad, J. M. Dwyer, G. S. Yochum, J. M. Boss, S. McWeeney, J. J. Dunn, G. Mandel, and R. H. Goodman. 2004. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119:1041–1054.
   PubMed Web of Science ®Google Scholar
• Jimi, E., S. Akiyama, T. Tsurukai, N. Okahashi, K. Kobayashi, N. Udagawa, T. Nishihara, N. Takahashi, and T. Suda. 1999. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J. Immunol. 163:434–442.
   PubMed Web of Science ®Google Scholar
• Jimi, E., I. Nakamura, L. T. Duong, T. Ikebe, N. Takahashi, G. A. Rodan, and T. Suda. 1999. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247:84–93.
   PubMed Web of Science ®Google Scholar
• Kabe, Y., J. Yamada, H. Uga, Y. Yamaguchi, T. Wada, and H. Handa. 2005. NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes. Mol. Cell. Biol. 25:512–522.
   PubMedGoogle Scholar
• Kaji, H., T. Sugimoto, M. Kanatani, M. Fukase, M. Kumegawa, and K. Chihara. 1996. Prostaglandin E2 stimulates osteoclast-like cell formation and bone resorbing activity via osteoblasts: role of cAMP-dependent protein kinase. J. Bone Miner. Res. 11:62–71.
   PubMed Web of Science ®Google Scholar
• Kamp, D., J. Cheng, P. Kapranov, M. Yamanaka, S. Brubaker, S. Cawley, J. Drenkow, A. Piccolboni, S. Bekiranov, G. Helt, H. Tammana, and T. R. Gingeras. 2004. Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res. 14:331–342.
   PubMedGoogle Scholar
• Kapranov, P., S. E. Cawley, J. Drenkow, S. Bekiranov, R. L. Strausberg, S. P. Fodor, and T. R. Gingeras. 2002. Large-scale transcriptional activity in chromosomes 21 and 22. Science 296:916–919.
   PubMed Web of Science ®Google Scholar
• Karst, M., G. Gorny, R. J. Galvin, and M. J. Oursler. 2004. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J. Cell Physiol. 200:99–106.
   PubMed Web of Science ®Google Scholar
• Kato, S., K. Sekine, T. Matsumoto, and T. Yoshizawa. 1998. Molecular genetics of vitamin D receptor acting in bone. J. Bone Miner. Metab. 16:65–71.
   Google Scholar
• Kim, S., N. K. Shevde, and J. W. Pike. 2005. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res. 20:305–317. [Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• Kim, T. H., L. O. Barrera, M. Zheng, C. Qu, M. A. Singer, T. A. Richmond, Y. Wu, R. D. Green, and B. Ren. 2005. A high resolution map of active promoters in the human genome. Nature 436:876–880.
   PubMed Web of Science ®Google Scholar
• Kim, T. H., L. O. Barrera, C. Qu, S. Van Calcar, N. D. Trinklein, S. J. Cooper, R. M. Luna, C. K. Glass, M. G. Rosenfeld, R. M. Myers, and B. Ren. 2005. Direct isolation and identification of promoters in the human genome. Genome Res. 15:830–839.
   PubMed Web of Science ®Google Scholar
• Kirmizis, A., S. M. Bartley, A. Kuzmichev, R. Margueron, D. Reinberg, R. Green, and P. J. Farnham. 2004. Silencing of human polycomb target genes is associated with methylation of histone H3 lys 27. Genes Dev. 18:1592–1605.
   PubMed Web of Science ®Google Scholar
• Kitazawa, S., R. Kitazawa, and S. Maeda. 1999. Promoter structure of mouse RANKL/TRANCE/ODF gene. Biochim. Biophys. Acta 1445:134–141.
   PubMedGoogle Scholar
• Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, T. Taniguchi, H. Takayanagi, and T. Takai. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428:758–763.
   PubMed Web of Science ®Google Scholar
• Kondo, H., J. Guo, and F. R. Bringhurst. 2002. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J. Bone Miner. Res. 17:1667–1679.
   PubMed Web of Science ®Google Scholar
• Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C. R. Dunstan, D. L. Lacey, T. W. Mak, W. J. Boyle, and J. M. Penninger. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315–323.
   PubMed Web of Science ®Google Scholar
• Lacey, D. L., E. Timm, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y. X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, and W. J. Boyle. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165–176.
   PubMed Web of Science ®Google Scholar
• Laganiere, J., G. Deblois, C. Lefebvre, A. R. Bataille, F. Robert, and V. Giguere. 2005. Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl. Acad. Sci. USA 102:11651–11656. [Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• Lee, S. K., and J. A. Lorenzo. 1999. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 140:3552–3561.
   PubMed Web of Science ®Google Scholar
• Liu, B. Y., J. Guo, B. Lanske, P. Divieti, H. M. Kronenberg, and F. R. Bringhurst. 1998. Conditionally immortalized murine bone marrow stromal cells mediate parathyroid hormone-dependent osteoclastogenesis in vitro. Endocrinology 139:1952–1964.
   PubMedGoogle Scholar
• Manolagas, S. C. 2000. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21:115–137.
   PubMed Web of Science ®Google Scholar
• Manolagas, S. C., R. S. Weinstein, R. L. Jilka, and A. M. Parfitt. 1998. Parathyroid hormone and corticosteroid-induced osteoporosis. Lancet 352:1940.
   PubMedGoogle Scholar
• Matsuo, K., D. L. Galson, C. Zhao, L. Peng, C. Laplace, K. Z. Wang, M. A. Bachler, H. Amano, H. Aburatani, H. Ishikawa, and E. F. Wagner. 2004. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. Biol. Chem. 279:26475–26480. [Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• Mundy, G. R. 2000. Pathogenesis of osteoporosis and challenges for drug delivery. Adv. Drug Delivery Rev. 42:165–173.
   PubMed Web of Science ®Google Scholar
• Nagpal, S., S. Na, and R. Rathnachalam. 2005. Noncalcemic actions of vitamin D receptor ligands. Endocr. Rev. 26:662–687. (First published 29 March 2005; 10.1210/er.2004-0002.)
   PubMed Web of Science ®Google Scholar
• Oberley, M. J., J. Tsao, P. Yau, and P. J. Farnham. 2004. High throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol. 376:315–334.
   PubMedGoogle Scholar
• O'Brien, C. A., B. Kern, I. Gubrij, G. Karsenty, and S. C. Manolagas. 2002. Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells. Bone 30:453–462.
   PubMedGoogle Scholar
• O'Sullivan, J. M., S. M. Tan-Wong, A. Morillon, B. Lee, J. Coles, J. Mellor, and N. J. Proudfoot. 2004. Gene loops juxtapose promoters and terminators in yeast. Nat. Genet. 36:1014–1018. [Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• Pike, J. W., and N. K. Shevde. 2005. The vitamin D receptor, p. 167–191. In D. Feldman, J. W. Pike, and F. H. Glorieux (ed.), Vitamin D, 2nd ed. Elsevier, San Diego, Calif.
   Google Scholar
• Romas, E., N. Udagawa, H. Zhou, T. Tamura, M. Saito, T. Taga, D. J. Hilton, T. Suda, K. W. Ng, and T. J. Martin. 1996. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J. Exp. Med. 183:2581–2591.
   PubMedGoogle Scholar
• Schubeler, D., D. M. MacAlpine, D. Scalzo, C. Wirbelauer, C. Kooperberg, F. van Leeuwen, D. E. Gottschling, L. P. O'Neill, B. M. Turner, J. Delrow, S. P. Bell, and M. Groudine. 2004. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 18:1263–1271.
   PubMed Web of Science ®Google Scholar
• Shevde, N. K., L. A. Plum, M. Clagett-Dame, H. Yamamoto, J. W. Pike, and H. F. DeLuca. 2002. A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation. Proc. Natl. Acad. Sci. USA 99:13487–13491. [Epub ahead of print.]
   PubMedGoogle Scholar
• Sivagurunathan, S., M. M. Muir, T. C. Brennan, J. P. Seale, and R. S. Mason. 2005. Influence of glucocorticoids on human osteoclast generation and activity. J. Bone Miner. Res. 20:390–398. [Epub ahead of print.]
   PubMedGoogle Scholar
• Smith, C. L., and B. W. O'Malley. 2004. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25:45–71.
   PubMed Web of Science ®Google Scholar
• Spotswood, H. T., and B. M. Turner. 2002. An increasingly complex code. J. Clin. Investig. 110:577–582.
   PubMedGoogle Scholar
• Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20:345–357.
   PubMed Web of Science ®Google Scholar
• Sutton, A. L., and P. N. MacDonald. 2003. Vitamin D: more than a “bone-a-fide” hormone. Mol. Endocrinol. 17:777–791. [Epub ahead of print.]
   PubMedGoogle Scholar
• Szutorisz, H., N. Dillon, and L. Tora. 2005. The role of enhancers as centres for general transcription factor recruitment. Trends Biochem. Sci. 30:593–599. [Epub ahead of print.]
   PubMedGoogle Scholar
• Takahashi, N., T. Akatsu, T. Sasaki, G. C. Nicholson, J. M. Moseley, T. J. Martin, and T. Suda. 1993. Induction of calcitonin receptors by 1,25-dihydroxyvitamin D in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 123:1504–1510.
   Google Scholar
• Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E. F. Wagner, T. W. Mak, T. Kodama, and T. Taniguchi. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3:889–901.
   PubMed Web of Science ®Google Scholar
• Tamura, T., N. Udagawa, N. Takahashi, C. Miyaura, S. Tanaka, Y. Yamada, Y. Koishihara, Y. Ohsugi, K. Kumaki, and T. Taga. 1993. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl. Acad. Sci. USA 90:11924–11928.
   PubMed Web of Science ®Google Scholar
• Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289:1504–1508.
   PubMed Web of Science ®Google Scholar
• Teitelbaum, S. L., and F. P. Ross. 2003. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4:638–649.
   PubMed Web of Science ®Google Scholar
• Tolhuis, B., R. J. Palstra, E. Splinter, F. Grosveld, and W. de Laat. 2002. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol. Cell 10:1453–1465.
   PubMed Web of Science ®Google Scholar
• Wani, M. R., K. Fuller, N. S. Kim, Y. Choi, and T. Chambers. 1999. Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. Endocrinology 140:1927–1935.
   PubMed Web of Science ®Google Scholar
• Weinstein, R. S., R. L. Jilka, A. M. Parfitt, and S. C. Manolagas. 1998. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Investig. 102:274–282.
   PubMed Web of Science ®Google Scholar
• Whyte, M. P., and S. Mumm. 2004. Heritable disorders of the RANKL/OPG/RANKL signaling pathway. Musculoskelet. Neuronal Interact. 4:254–267.
   PubMedGoogle Scholar
• Yamada, K., D. T. Duong, D. K. Scott, J. C. Wang, and D. K. Granner. 1999. CCAAT/enhancer-binding protein beta is an accessory factor for the glucocorticoid response from the cAMP response element in the rat phosphoenolpyruvate carboxykinase gene promoter. J. Biol. Chem. 274:5880–5888.
   PubMedGoogle Scholar
• Yamamoto, H., N. K. Shevde, A. Warrier, L. A. Plum, H. F. DeLuca, and J. W. Pike. 2003. 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J. Biol. Chem. 278:31756–31765. [Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• Zella, L. A., S. Kim, N. K. Shevde, and J. W. Pike. 2006. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol. Endocrinol. 20:1231–1247. (First published 23 February 2006; 10.1210/me.2000-0015.)
   PubMed Web of Science ®Google Scholar